Handelsbanken Fonder Ab Dyne Therapeutics, Inc. Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
A detailed history of Handelsbanken Fonder Ab transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 22,500 shares of DYN stock, worth $310,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,500
Previous 19,300
16.58%
Holding current value
$310,050
Previous $693,000
23.52%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
214Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$111 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$102 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$102 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$92.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$87.9 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $713M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...